Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


6th isirv-AVG Conference - Advances in Respiratory Virus Therapeutics

Add this event to your calendar: iCal   Google Calendar

Who should attend?

This Conference will be of interest to clinicians, medical scientists from academia, pharmaceutical and biotech companies, and public health experts.


 The Conference will address both pre-clinical and clinical advances in therapeutic and prophylactic agents for influenza, RSV and other respiratory viruses spanning antivirals, monoclonal and polyclonal antibodies and immunomodulatory agents. 
It will also include consideration of clinical development pathways, trial design and study endpoints as well as regulatory issues central to advancing such agents to clinical practice. 

The programme will encompass the following topics:

• Preclinical Development 
• Clinical Trial Design and Regulatory Issues 
• Clinical Trial Papers 
• Pathogenesis, Biomarkers and Diagnostics
• Updates on Emerging Threats and Therapeutics and Antiviral Resistance


Early Non-Member Registration $850 To 14 September 2018 Early ISIRV Member Registration $700 To 14 September 2018 Late Non-Member Registration $995 To 5 November 2018 Late ISIRV Member Registration $845 To 5 November 2018 Student Registration $400 To 5 November 2018


Lida DeSouza

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.